Every weekend, I dive into our insider activity tracker looking for the most interesting and bullish buys — and this week, it was private equity shops and hedge funds leading the charge.
It's that time of the month when we zoom out and look at the bigger picture (seems like a good time to do that, don't you think?) The market has been trying to make sense of the trend, so let's try and do that as well...
That this is an unfamiliar and uncomfortable environment for many investors goes without saying. It was unforeseen to the extent that it is at odds with recent experience. For passive investors, the...
Chemicals and Fertilizing stocks have been among the sectors that seem to be "benefiting" from supply shocks in the system stemming from the war in Ukraine, as well as just general inflation touching the price of everything (except tech stocks,...
The largest insider buy on today's list is a Form 4 filing by Column Group, which reported the purchase of approximately $5.8 million in NGM Biopharmaceuticals $NGM.
Kevin Riley, the CEO and president of First Interstate BancSystem $FIBK,...
